(Q34008348)

30 July 2017

1 reference

title

Intrathecal drug therapy for long-term pain management (English)

1 reference

30 July 2017

0 references

Virginia L Ghafoor

1

1 reference

30 July 2017

Mikhail Epshteyn

2

1 reference

30 July 2017

Gary H Carlson

3

1 reference

30 July 2017

Donald M Terhaar

4

1 reference

30 July 2017

Orlando Charry

5

1 reference

30 July 2017

Pamela K Phelps

6

1 reference

30 July 2017

publication date

1 December 2007

1 reference

American Journal of Health-System Pharmacy

30 July 2017

published in

1 reference

30 July 2017

volume

64

1 reference

30 July 2017

issue

23

1 reference

30 July 2017

page(s)

2447-2461

1 reference

Clinical guidelines for intraspinal infusion: report of an expert panel. PolyAnalgesic Consensus Conference 2000.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Understanding the physiology and pharmacology of epidural and intrathecal opioids

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Spinal descent of cerebrospinal fluid in man.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Epidural and intrathecal analgesia is effective in treating refractory cancer pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Evaluation of patients for implantable pain modalities: medical and behavioral assessment

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Clinical realities and economic considerations: patient selection in intrathecal therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Neuraxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Clinical realities and economic considerations: economics of intrathecal therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Intrathecal morphine for chronic benign pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

The role of intrathecal drugs in the treatment of acute pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Location, location, location

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Outcome of intrathecal opioids in chronic non-cancer pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Response of intractable pain to continuous intrathecal morphine: a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Long-term intrathecal infusion of drug combinations for chronic back and leg pain.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

A review of intrathecal fentanyl and sufentanil for the treatment of chronic pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Endocrine consequences of long-term intrathecal administration of opioids

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Hypogonadism in patients treated with intrathecal morphine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Myoclonic seizure activity with chronic high-dose spinal opioid administration

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Meniere-like syndrome following epidural morphine analgesia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Epidural opioids as a cause of vertical nystagmus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Efficacy of intrathecal bupivacaine: how important is the flow rate?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory nonmalignant pain: a comparison between the epidural and the intrathecal approach with externalized or implanted catheters

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Should intrathecal lidocaine be used in the 21st century?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Long-term intrathecal administration of midazolam and clonidine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Calcium and sodium channel antagonists for the treatment of pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

A consensus statement regarding the present suggested titration for prialt (ziconotide)

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Effects of intrathecal baclofen on chronic spinal cord injury pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Intrathecal baclofen is analgesic in patients with chronic pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Intrathecal baclofen withdrawal mimicking sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Management of intrathecal catheter-tip inflammatory masses: a consensus statement

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Spinal cord lesion after long-term intrathecal clonidine and bupivacaine treatment for the management of intractable pain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Neurologic complications including paralysis after a medication error involving implanted intrathecal catheters

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Encapsulation of an intrathecal catheter

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Prevention of intrathecal drug delivery catheter-related complications

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Delayed complications of discontinuation of intrathecal baclofen therapy: resurgence of dyssynergic voiding, which triggered off autonomic dysreflexia and hydronephrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Pruritus after intrathecal baclofen withdrawal: A retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

A benefit-risk assessment of baclofen in severe spinal spasticity.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Withdrawal symptoms in a patient receiving intrathecal morphine via an infusion pump

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable SynchroMed pumps

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Stability of admixture containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Stability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery system

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Stability and Compatibility of Morphine-Clonidine Admixtures in an Implantable Infusion System

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Stability of clonidine in clonidine-hydromorphone mixture from implanted intrathecal infusion pumps in chronic pain patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Calculation methods for the continuous intrathecal infusion of a solution containing two or three drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

Massive hydromorphone dose delivered subcutaneously instead of intrathecally: guidelines for prevention and management of opioid, local anesthetic, and clonidine overdose.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060204

31 March 2020

Identifiers

DOI

10.2146/AJHP060204

1 reference

30 July 2017

1 reference